Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Well, a global leader in NGS library construction technology, today announced the launch of MosaiX, a next-generation library prep kit designed to streamline a wide range of high-throughput ...

Researchers found that distinct tumor clones in uveal melanoma determine where metastases form. Clones with BAP1 mutations ...

Moby summary of GeneDx Holdings Corp.'s Q4 2025 earnings call ...

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

A growing body of research is pushing cancer science toward a radical shift: detecting and stopping the disease years or even decades before a tumor ever forms. Multiple studies now show that ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

India's disease burden is undergoing a structural shift. According to the recent data, non-communicable diseases account for ...